Perdigoto, A. L., Deng, S., Du, K. C., Kuchroo, M., Burkhardt, D. B., Tong, A., Israel, G., Robert, M. E., Weisberg, S. P., Kirkiles-Smith, N., Stamatouli, A. M., Kluger, H. M., Quandt, Z., Young, A., Yang, M.-L., Mamula, M. J., Pober, J. S., Anderson, M. S., Krishnaswamy, S., & Herold, K. C. (2022). Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor–induced diabetes. JCI Insight, 7(17). https://doi.org/10.1172/jci.insight.156330
Columbia Affiliation:
Subjects:
Cancer Immunotherapy
(OpenAlex Topic)
Pancreatic Cancer Research and Treatment
(OpenAlex Topic)
Natural Killer Cells in Immunity
(OpenAlex Topic)
Diabetes Mellitus
(MeSH)
Publication Type:
Article
Unique ID:
10.1172/jci.insight.156330
PMID:
Journal:
Publication Date:
Data Source:
PubMed